10-K Decoder · All companies

Tango Therapeutics, Inc.

TNGX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$62.4M$42.1M+48.3%
Operating income−$111M−$146M+23.6%
Net income−$102M−$130M+22.0%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026

$Q3 2026Year earlierChange
Revenue$0K$53.8M−100%
Operating income−$78.1M$14.1M
Net income−$68.4M$15.9M

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Tango's revenue in FY2025?
$62.4M in FY2025 (Fiscal year ended Dec 31, 2025), +48.3% vs $42.1M a year earlier, per its 10-K filed Mar 2026.
Was Tango profitable in FY2025?
No: net income was −$102M and operating income −$111M in FY2025.
What was Tango's revenue in Q3 2026?
$0K (−100% vs a year earlier), per its Form 10-Q filed Nov 9, 2026.